Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-26-000175

Director sold 318 shares at $423.73 ($134,746)

  • Director acquired 943 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Bhatia Sangeeta N. · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-05-01 Grant or award : show line 1 in the form 10b5-1 +943 5,242 D
2026-05-04 Sale : show line 2 in the form 10b5-1 −318 $423.73 $134,746 4,924 D
Open-market sales · 318 sh · avg $423.73 · $134,746
Loading xslF345X06/wk-form4_1778014276.xml…